Emtricitabine And Tenofovir Disoproxil Fumarate
Product Images NDC 53002-1653

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Emtricitabine And Tenofovir Disoproxil Fumarate (NDC 53002-1653). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure 1 (Emtriteno Str1)

Chemical structure diagram of the active ingredients Emtricitabine and Tenofovir Disoproxil Fumarate, showing their molecular components and bonds as depicted in the image.*

FDA Label Image

Chemical Structure 2 (Emtriteno Str2)

Chemical structure of Emtricitabine and Tenofovir Disoproxil Fumarate, showing molecular diagrams with labeled atoms including nitrogen, oxygen, phosphorus, and carbon groups characteristic of these antiviral agents.*

FDA Label Image

Label Image (Lbl530021653)

Packaging label for Emtricitabine and Tenofovir Disoproxil Fumarate 200-300 mg tablets by RPK Pharmaceuticals, Inc. The label indicates 30 tablets with directions to "Take as directed." It includes barcode, lot number, expiration date, patient information fields, and billing NDC details. Clinic name and prescriber information fields are also present but blank.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.